In the race to solve Alzheimer’s disease, scientists find more needles in the haystack

April 20, 2022

Thanks to international collaboration, more genetic variations for Alzheimer’s disease are known today than ever before. The list of gene variants recognized for late-onset Alzheimer’s grew from one in 2009 to 40 in 2022. This month, scientists published a list of 75, some of which are considered as prime drug targets. Drug development is underway.




Team discovers novel drug target for Alzheimer’s and related dementias

April 14, 2022

Researchers from UT Health San Antonio today reported the discovery of a novel mechanism by which pathological forms of tau protein cause neurons to die. Alzheimer’s disease and chronic traumatic encephalopathy (CTE) are among more than 20 disorders that include tau protein pathology. The newly found mechanism of tau-induced damage can be altered pharmacologically, the scientists noted, making it a novel target for drug development.

Photo of a brain made of multicolored wires.




The Center for Mucosal & Microbiome Biology at UT Health San Antonio

April 5, 2022

UT Health San Antonio recently introduced its newest research center, the Center for Mucosal & Microbiome Biology, located within the Joe R. and Teresa Lozano Long School of Medicine. Led by Mansour M. Zadeh, PhD, distinguished professor of medicine in the Division of Gastroenterology and Nutrition, the center will function as a collaborative entity for […]




Black patients with cancer fare worse with COVID-19, study shows

April 1, 2022

Structural racism, rather than disease, leads to inequities, authors write Black patients with cancer experienced significantly worse outcomes after COVID-19 diagnosis than non-Hispanic white cancer patients in a study published March 28 in JAMA Network Open. Investigators of the COVID-19 and Cancer Consortium (https://ccc19.org/), which includes more than 125 cancer centers and other organizations, studied […]